Apr 1 2010
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based biopharmaceutical company, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities Commission for a best efforts offering to sell up to $40.0 million of units consisting of one share of common stock and a warrant to purchase 0.20 shares of common stock. The offering anticipates including shares of common stock to be sold by selling stockholders.
The specific number of units to be offered and the price range for the offering have yet to be determined. The purpose of the offering will be to raise funds to support clinical trials of the Company's vaccines and for general business purposes.
SOURCE GeoVax Labs, Inc.